RAiD 10.26259/3c851394
Identifying unique immune mechanisms in melanoma patients with brain recurrence or pre-surgical progression on neoadjuvant therapy

Dates

Start Date
01-Jan-2022
End Date
31-Dec-2025

Titles

Title
Identifying unique immune mechanisms in melanoma patients with brain recurrence or pre-surgical progression on neoadjuvant therapy
Title Type
Primary
Title Type: Primary Preferred full description or abstract.
Start Date
01-Jan-2022
End Date
---
Language
English

Descriptions

Description
This research project is designed to uncover the immunological drivers of treatment resistance in melanoma patients, specifically those who recur in the brain or exhibit disease progression before surgery while on neoadjuvant therapy. By identifying unique immune populations and markers of resistance, this project aims to better understand the underlying mechanisms that contribute to immunotherapy resistance and super progression in these patients. The insights gained could lead to the development or targeted therapeutic strategies the circumvent resistance and that can be further tested in mechanistic or pre-clinical models, ultimately improving patient outcomes and survival rates in these particularly challenging cases.
Description Type
Primary
Description Type: Primary Preferred full description or abstract
Language
English

Contributors

Contributor
https://orcid.org/0009-0004-5275-7264
Leader
Yes
Contact
Yes
Positions
Position
Co-investigator or Collaborator
Position: Co-investigator or Collaborator A Co-Investigator is a senior or key investigator involved in a research project who does not have the overall responsibility and authority of the Principal Investigator
Start Date
01-Jan-2022
End Date
31-Dec-2025
Roles
Conceptualization
Contributor
https://orcid.org/0009-0006-7597-4813
Leader
No
Contact
Yes
Positions
Position
Co-investigator or Collaborator
Position: Co-investigator or Collaborator A Co-Investigator is a senior or key investigator involved in a research project who does not have the overall responsibility and authority of the Principal Investigator
Start Date
01-Jan-2022
End Date
31-Dec-2025
Roles
Supervision

Organisations

Organisation ID
https://ror.org/02stey378
Roles
Role
Lead Research Organisation
Role: Lead Research Organisation The research organistion administratively responsible for the project; administering organisation
Start Date
2022-01-01
End Date
---

RelatedObjects

No Entries

Alternate Identifier

No Entries

Alternate URLs

No Entries

Related RAiDs

No Entries

Access

Type
Open Access
Type: Open Access Open access refers to a resource that is immediately and permanently online, and free for all on the Web, without financial and technical barriers.The resource is either stored in the repository or referenced to an external journal or trustworthy archive.
Language
eng
Text
Access statement example text...
Embargo Expiry
2026-03-18

Subjects

Subject
Oncology and carcinogenesis not elsewhere classified (321199)
Keywords
Text
Subject keyword example text...
Language
eng

Raw Data

{
  "metadata": {
    "created": 1742290468,
    "updated": 1742955829
  },
  "identifier": {
    "id": "http://raid.local/10.26259/3c851394",
    "schemaUri": "https://raid.org/",
    "registrationAgency": {
      "id": "https://ror.org/038sjwq14",
      "schemaUri": "https://ror.org/"
    },
    "owner": {
      "id": "https://ror.org/02stey378",
      "schemaUri": "https://ror.org/",
      "servicePoint": 20000003
    },
    "raidAgencyUrl": "https://prod.static.raid.org.au/10.26259/3c851394",
    "license": "Creative Commons CC-0",
    "version": 2
  },
  "title": [
    {
      "text": "Identifying unique immune mechanisms in melanoma patients with brain recurrence or pre-surgical progression on neoadjuvant therapy",
      "type": {
        "id": "https://vocabulary.raid.org/title.type.schema/5",
        "schemaUri": "https://vocabulary.raid.org/title.type.schema/376"
      },
      "startDate": "2022-01-01",
      "language": {
        "id": "eng",
        "schemaUri": "https://www.iso.org/standard/74575.html"
      }
    }
  ],
  "date": {
    "startDate": "2022-01-01",
    "endDate": "2025-12-31"
  },
  "description": [
    {
      "text": "This research project is designed to uncover the immunological drivers of treatment resistance in melanoma patients, specifically those who recur in the brain or exhibit disease progression before surgery while on neoadjuvant therapy. By identifying unique immune populations and markers of resistance, this project aims to better understand the underlying mechanisms that contribute to immunotherapy resistance and super progression in these patients. The insights gained could lead to the development or targeted therapeutic strategies the circumvent resistance and that can be further tested in mechanistic or pre-clinical models, ultimately improving patient outcomes and survival rates in these particularly challenging cases.",
      "type": {
        "id": "https://vocabulary.raid.org/description.type.schema/318",
        "schemaUri": "https://vocabulary.raid.org/description.type.schema/320"
      },
      "language": {
        "id": "eng",
        "schemaUri": "https://www.iso.org/standard/74575.html"
      }
    }
  ],
  "access": {
    "type": {
      "id": "https://vocabularies.coar-repositories.org/access_rights/c_abf2/",
      "schemaUri": "https://vocabularies.coar-repositories.org/access_rights/"
    },
    "statement": {
      "text": "Access statement example text...",
      "language": {
        "id": "eng",
        "schemaUri": "https://www.iso.org/standard/74575.html"
      }
    },
    "embargoExpiry": "2026-03-18"
  },
  "alternateUrl": [],
  "contributor": [
    {
      "id": "https://orcid.org/0009-0004-5275-7264",
      "schemaUri": "https://orcid.org/",
      "status": "UNAUTHENTICATED",
      "uuid": "45c36ee4-9e68-471f-b41e-f80f4662a27f",
      "position": [
        {
          "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305",
          "id": "https://vocabulary.raid.org/contributor.position.schema/308",
          "startDate": "2022-01-01",
          "endDate": "2025-12-31"
        }
      ],
      "role": [
        {
          "schemaUri": "https://credit.niso.org/",
          "id": "https://credit.niso.org/contributor-roles/conceptualization/"
        }
      ],
      "leader": true,
      "contact": true
    },
    {
      "id": "https://orcid.org/0009-0006-7597-4813",
      "schemaUri": "https://orcid.org/",
      "status": "UNAUTHENTICATED",
      "uuid": "68fe4021-faa6-4062-ace8-6251ca3a0ca6",
      "position": [
        {
          "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305",
          "id": "https://vocabulary.raid.org/contributor.position.schema/308",
          "startDate": "2022-01-01",
          "endDate": "2025-12-31"
        }
      ],
      "role": [
        {
          "schemaUri": "https://credit.niso.org/",
          "id": "https://credit.niso.org/contributor-roles/supervision/"
        }
      ],
      "leader": false,
      "contact": true
    }
  ],
  "organisation": [
    {
      "id": "https://ror.org/02stey378",
      "schemaUri": "https://ror.org/",
      "role": [
        {
          "schemaUri": "https://vocabulary.raid.org/organisation.role.schema/359",
          "id": "https://vocabulary.raid.org/organisation.role.schema/182",
          "startDate": "2022-01-01",
          "endDate": ""
        }
      ]
    }
  ],
  "subject": [
    {
      "id": "https://linked.data.gov.au/def/anzsrc-for/2020/321199",
      "schemaUri": "https://vocabs.ardc.edu.au/viewById/316",
      "keyword": [
        {
          "text": "Subject keyword example text...",
          "language": {
            "id": "eng",
            "schemaUri": "https://www.iso.org/standard/74575.html"
          }
        }
      ]
    }
  ],
  "relatedRaid": [],
  "relatedObject": [],
  "alternateIdentifier": [],
  "spatialCoverage": []
}